S-1/A: Kindly MD Inks Executive Employment Agreement with Adam Cox, Outlines Compensation and Responsibilities

Kindly MD formalizes Adam Cox's role as COO with a comprehensive employment agreement detailing compensation, responsibilities, and post-employment obligations.

Summary

• Kindly MD, Inc. has entered into an employment agreement with Adam Cox, effective May 1st, 2022, and executed December 30, 2022, for the role of Chief Operating Officer (COO).
• The agreement outlines Cox's responsibilities, including performing duties related to the COO position and additional management roles designated by the Board.
• Cox is expected to devote substantial time and effort to the Company and is restricted from participating in activities adverse to the Company's interests without Board approval.
• The agreement includes non-competition and non-solicitation covenants for one year post-employment.
• Cox's annual salary is set at $138,000, subject to annual review and potential increases, including a raise to $224,000 upon successful completion of a $6 million corporate fundraising.
• Cox received 34,992 shares of restricted Kindly common stock which is considered fully vested and is eligible for additional stock awards, including 75,000 newly-issued restricted common stock.
• The agreement details vesting schedules for these stock awards, contingent on fundraising milestones and continuous employment.
• Cox is eligible for incentive compensation, including a performance bonus payment based on employee turnover, operating margin improvement, and maintaining positive operating cash flow.
• The agreement includes provisions for participation in Company benefits, reimbursement of business expenses, indemnification, and inclusion in stock option plans.
• Termination clauses cover death, disability, termination for cause, and termination for good reason, with specific obligations for the Company upon termination.
• A waiver and release agreement is attached as Exhibit A, outlining the conditions for receiving severance payments and benefits.
• The agreement is governed by Utah law, with disputes to be settled through binding arbitration in Salt Lake City, Utah.

Sentiment

Score: 7

Explanation: The document is a standard employment agreement, suggesting a neutral to positive outlook. The terms are generally favorable for both the Company and the executive, with incentives aligned with Company growth.

Positives

• Clear definition of responsibilities and expectations for the COO role.
• Incentive structure tied to key performance indicators, aligning executive interests with Company goals.
• Comprehensive benefits package, including health insurance, disability coverage, and expense reimbursement.
• Indemnification clause provides protection for the executive in connection with their duties.
• Stock awards offer potential for significant financial upside based on Company performance and milestones.

Negatives

• Non-competition and non-solicitation clauses may limit future career options for the executive.
• Termination for cause provisions could be subject to interpretation and potential disputes.
• Salary increases and stock vesting are contingent on achieving specific fundraising milestones, which may not be guaranteed.

Risks

• The Company's ability to achieve fundraising milestones is subject to market conditions and investor sentiment.
• Enforceability of non-competition and non-solicitation clauses can vary by jurisdiction.
• Potential for disputes over the interpretation of 'cause' for termination.
• Changes in federal cannabis laws could impact the Company's business and the executive's role.

Future Outlook

The agreement anticipates potential salary increases and stock vesting based on the Company's financial performance and fundraising success. It also includes provisions for automatic renewal of the agreement term.

Industry Context

The agreement reflects standard practices for executive employment in growth-oriented companies, including performance-based incentives and protective covenants. The specific terms, such as the salary and stock awards, are likely influenced by the Company's stage of development and industry dynamics.

Comparison to Industry Standards

• Executive compensation packages in similar healthcare and technology companies often include a base salary, performance-based bonuses, and equity incentives.
• Non-competition and non-solicitation clauses are common in executive employment agreements to protect the company's interests.
• The specific terms of the agreement, such as the salary and stock awards, would be benchmarked against comparable companies in the healthcare data and alternative medicine sectors.
• The vesting schedules for stock awards are typical for incentivizing long-term commitment and achieving key milestones.

Stakeholder Impact

• Shareholders: The agreement aims to secure key leadership, potentially contributing to long-term value creation.
• Employees: The agreement sets a precedent for executive compensation and performance expectations.
• Customers: The agreement's focus on Company growth and service quality could indirectly benefit customers.
• Executive: The agreement provides clarity on compensation, responsibilities, and benefits.

Next Steps

• Annual review of the executive's salary by the compensation committee.
• Potential increase in salary and vesting of stock awards upon successful completion of fundraising milestones.
• Ongoing performance monitoring to determine eligibility for incentive compensation.
• Compliance with non-competition and non-solicitation clauses post-employment.

Key Dates

Keywords

employment agreement, chief operating officer, COO, executive compensation, stock options, incentive compensation, non-competition, non-solicitation, Kindly MD, Adam Cox